Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
K&f Growth Acquisition II A | KFII | Mar 28, 2025 | 9.96 | 0.00 |
K&F Growth Acquisition II Unit | KFIIU | Mar 28, 2025 | 10.09 | 0.00 |
Kadant | KAI | Mar 28, 2025 | 335.95 | -4.34 |
Kairos Pharma | KAPA | Mar 28, 2025 | 0.92 | -5.01 |
Kaiser Aluminium | KALU | Mar 28, 2025 | 62.09 | -4.34 |
Kaival Brands Innovations Group | KAVL | Mar 28, 2025 | 0.56 | -1.56 |
Kaixin Holdings | KXIN | Mar 28, 2025 | 0.96 | +1.46 |
Kala Bio | KALA | Mar 28, 2025 | 6.05 | -4.27 |
Kalaris Therapeutics | KLRS | Mar 28, 2025 | 8.60 | 0.00 |
Kaltura | KLTR | Mar 28, 2025 | 1.94 | +1.04 |
KalVista Pharmaceuticals | KALV | Mar 28, 2025 | 11.93 | -3.32 |
Kamada | KMDA | Mar 28, 2025 | 6.75 | -1.17 |
Kandi Technologies Group | KNDI | Mar 28, 2025 | 1.38 | +1.47 |
Kanzhun ADR | BZ | Mar 28, 2025 | 19.46 | -2.99 |
Karat Packaging | KRT | Mar 28, 2025 | 27.25 | -1.48 |
Karman | KRMN | Mar 28, 2025 | 35.08 | 0.00 |
Karooooo | KARO | Mar 28, 2025 | 42.66 | -0.88 |
Kartoon Studios | TOON | Mar 28, 2025 | 0.60 | -0.69 |
Karyopharm Therapeutics | KPTI | Mar 28, 2025 | 4.16 | -4.37 |
Katapult | KPLT | Mar 28, 2025 | 11.90 | -8.32 |
Kayne Anderson BDC | KBDC | Mar 28, 2025 | 16.51 | -1.20 |
Kayne Anderson Energy Infrastructure Fund | KYN | Mar 28, 2025 | 12.92 | +0.78 |
Kazia Therapeutics ADR | KZIA | Mar 28, 2025 | 0.88 | -7.36 |
KB Financial Group ADR | KB | Mar 28, 2025 | 53.36 | -3.21 |
KB Home | KBH | Mar 28, 2025 | 57.73 | -2.50 |
KBR | KBR | Mar 28, 2025 | 50.35 | -1.62 |
KBW Bank Powershares | KBWB | Mar 28, 2025 | 61.95 | -2.44 |
KBW High Div Yield Financial Powershares | KBWD | Mar 28, 2025 | 14.42 | -1.77 |
KBW Prem Yield Equity REIT Powershares | KBWY | Mar 28, 2025 | 16.63 | -0.36 |
KBW Prop & Casuality Insur Powershares | KBWP | Mar 28, 2025 | 123.32 | -0.32 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.